{"id":"W2017811988","doi":"10.1007/s00280-008-0743-5","title":"A phase I pharmacokinetic study of hypoxic abdominal stop-flow perfusion with gemcitabine in patients with advanced pancreatic cancer and refractory malignant ascites","year":2008,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université de Sherbrooke","funders":"Eli Lilly and Company","keywords":"Gemcitabine; Medicine; Pancreatic cancer; Tolerability; Pharmacokinetics; Perfusion; Urology; Extracorporeal; Internal medicine; Chemotherapy; Cancer; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001052819,0.00135346,0.002355131,0.000469048,0.0006595615,0.001034925,0.0008809016,0.00109001,0.002133678],"category_scores_gemma":[0.001172425,0.0007336225,0.001109423,0.0006848279,0.001500227,0.001309759,0.0004129445,0.003799423,0.000459531],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001051423,"about_ca_system_score_gemma":0.001767984,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001647762,"about_ca_topic_score_gemma":0.002477457,"domain_scores_codex":[0.999427,0.0002900596,0.00001598237,0.0001003639,0.00003818677,0.000128434],"domain_scores_gemma":[0.9990731,0.0002126534,0.0001586863,0.000124081,0.00003262738,0.0003987798],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.721301,0.1177601,0.008929646,0.0004596871,0.0010652,0.00054348,0.0007548849,0.006274336,0.06567992,0.0005990459,0.002614151,0.07401852],"study_design_scores_gemma":[0.2656684,0.7069313,0.01382285,0.00002220729,0.0004348908,0.0004104797,0.0001821282,0.002391177,0.007244116,0.0002191114,0.0026164,0.00005689731],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9976491,0.000437074,0.0003921942,0.0001554171,0.00004389557,0.0004837263,0.0001974868,0.00002894025,0.0006121583],"genre_scores_gemma":[0.9963776,0.0006485441,0.0008139734,0.0002487042,0.0001128097,0.0006011768,0.0004504365,0.00002872968,0.0007179704],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002355131,"threshold_uncertainty_score":0.007628679,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02038561759059088,"score_gpt":0.3470636198025388,"score_spread":0.3266780022119479,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}